Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TARS. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Deep Track Capital, LP | 3,600,000 | $253M | INCREASED |
| BlackRock, Inc. | 3,552,612 | $249M | DECREASED |
| RTW INVESTMENTS, LP | 3,346,025 | $235M | INCREASED |
| Paradigm Biocapital Advisors LP | 2,562,154 | $180M | UNCHANGED |
| JANUS HENDERSON GROUP PLC | 2,240,963 | $157M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Bobak R. Azamian (President/CEO and Board Chair) | SELL | 5,418 | $335K | 2026-06-17 |
| Bobak R. Azamian (President/CEO and Board Chair) | SELL | 4,582 | $281K | 2026-06-17 |
| William J Link PHD (Director) | SELL | 1,928 | $121K | 2026-06-15 |
| William J Link PHD (Director) | SELL | 10,572 | $655K | 2026-06-15 |
| Katherine Goodrich (Director) | SELL | 2,954 | $183K | 2026-06-15 |
Full institutional holdings, insider history, and congressional trades for Tarsus Pharmaceuticals, Inc. Common Stock on SentiSense.